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Abstract
Sp1 transcription factor regulates the expression of multiple genes, including the Sp1 gene itself. We
analyzed the ability of different cell cycle regulatory proteins to interact with Sp1 and to affect Sp1
promoter activity. Using an antibody array, we observed that CDK4, SKP2, Rad51, BRCA2 and p21
could interact with Sp1 and we confirmed these interactions by co-immunoprecipitation. CDK4,
SKP2, Rad51, BRCA2 and p21 also activated the Sp1 promoter. Among the known Sp1-interacting
proteins, E2F-DP1, Cyclin D1, Stat3 and Rb activated the Sp1 promoter, whereas p53 and NFκB
inhibited it. The proteins that regulated Sp1 gene expression were shown by positive chromatin
immunoprecipitation to be bound to the Sp1 promoter. Moreover, SKP2, BRCA2, p21, E2F-DP1,
Stat3, Rb, p53 and NFκB had similar effects on an artificial promoter containing only Sp1 binding
sites. Transient transfections of CDK4, Rad51, E2F-DP1, p21 and Stat3 increased mRNA expression
from the endogenous Sp1 gene in HeLa cells whereas overexpression of NFκB, and p53 decreased
Sp1 mRNA levels. p21 expression from a stably integrated inducible promoter in HT1080 cells
activated Sp1 expression at the promoter and mRNA levels, but at the same time it decreased Sp1
protein levels due to the activation of Sp1 degradation. The observed multiple effects of cell cycle
regulators on Sp1 suggest that Sp1 may be a key mediator of cell cycle associated changes in gene
expression.
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Introduction
Sp1 transcription factor regulates a wide range of cellular processes,1 including cell cycle
regulation, hormonal activation, apoptosis and angiogenesis.2 It belongs to a family of nuclear
proteins, called Sp/KLF (specificity protein/Krüppel-like factor) that recognizes the GC-rich
DNA-binding core sequences GC-(GGGGCGGGG) and GT-(GGTGTGGGG) boxes due to
the presence of three conserved Cys2His2 zinc fingers that form the DNA-binding domain.3
Regulation of Sp1-dependent transcription can be affected by changes in Sp1 abundance, as it
occurs during the cell cycle with an increase during G1 phase; DNA binding activity or
transactivation activity, and it can involve direct protein-protein interactions with other nuclear
factors in which the other factor is not necessarily bound to promoter DNA. Several protein-
binding sites have been identified throughout Sp1.4 For example, Sp1-interacting proteins
include several viral proteins; members of the basal transcription machinery, several
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transcription activators and cell cycle regulators.4 In the latter case, the retinoblastoma protein
has been described to interact physically with Sp1 in a complex that enhances the transcriptional
activation by Sp1.5 In addition, Sp1 can also interact with the E2F-family of transcription
factors which is believed to integrate cell cycle progression with transcription through its
cyclical interactions with important cell cycle regulators, such as Rb, cyclins and cyclin-
dependent kinases.6 Moreover, Sp factors have been proposed to be essential for the
transactivation of the p21Cip1 promoter by members of the p53 family of proteins.7
Posttranslational modifications also regulate Sp1 activity, including glycosylation, acetylation,
phosphorylation and sumoylation.4,8 Many kinases are able to phosphorylate Sp1 and its
phosphorylation state could also be affected by protein phosphatases.9 CyclinE-CDK2 and
CyclinA-CDK2 complexes which are important regulators of the mammalian cell cycle,
phosphorylate Sp1 forming stable complexes with this transcription factor bound to the DNA.
10
We previously described the cloning of the 5′-flanking region of the human Sp1 gene, where
a number of putative binding sites for transcription factors were found. Within the minimal
promoter sequence, expanding 217 bp from the transcription start site, two Sp1 binding sites
were described. Sp1 promoter was mainly regulated by Sp1, Sp3 and NF-Y, although E2F was
also found to bind and activate the Sp1 promoter.11,12
In the present study we performed a more detailed analysis of the Sp1 promoter taking into
account its regulation by protein-protein interactions. Using a proteomic array system, we first
screened for new Sp1-interacting proteins among cell cycle regulators. We confirmed by
coimmunoprecipitation the interaction of Sp1 with Rad51, CDK4, SKP2, BRCA2 and p21 and
we studied the effect of the overexpression of these proteins both on the Sp1 promoter and on
the endogenous Sp1 mRNA levels. Other known Sp1-interacting proteins were also tested for
their effect on Sp1 regulation. We analyzed the regulation of the Sp1 promoter in situ by
chromatin immunoprecipitation using specific antibodies against the different proteins studied.
Additionally, an artificial Sp1-dependent promoter was used in order to ascertain if the effects
observed were unique to the Sp1 promoter or a general mechanism regulating Sp1-dependent
transcription. Interaction of Sp1 with p21 was further studied using HT1080 p21-9 cells with
inducible p21 expression.13 Although p21 activated Sp1 transcription both at the promoter and
mRNA levels, it did not increase Sp1 protein levels due to the activation of Sp1 protein
degradation. The observed multiple effects of cell cycle regulators on Sp1 suggest that Sp1
may be a key mediator of cell cycle associated changes in gene expression.
Results
Sp1 interacts with different cell cycle regulators
To identify proteins that might interact with transcription factor Sp1, whole cell extracts from
HeLa cells were screened for Sp1 interactors using an antibody array (Hypromatrix). Among
all the Sp1-interacting proteins identified in the Antibody Array, the following were selected
for further study: CDK4 and p21, that play a pivotal role in the control of eukaryotic cell cycle;
SKP2 that binds to different substrates for ubiquitination by the SCF complex; Rad51 and
BRCA2 that participate in DNA-damage responses; and Stat3, p53, NFκB, E2F and Rb for
which the interaction with Sp1 had been previously described and that were used as positive
controls.
The interactions between Sp1 and several selected proteins identified in the antibody array
were confirmed by coimmunoprecipitation. Sp1, CDK4, SKP2, Rad51 and BRCA2 were
immunoprecipitated from HeLa whole-cell extracts using specific antibodies and the presence
of Sp1 in the immunoprecipitates was determined by western blot analysis. Sp1 was detected
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in the immunoprecipitates of antibodies against these proteins, demonstrating that all the
selected proteins interacted with Sp1 (Fig. 1A). No signal corresponding to Sp1 was detected
when the immunoprecipitation was performed with unspecific IgGs. The interaction between
Sp1 and p21 was established by immunoprecipitation using a p21-specific antibody and HeLa
cells overexpressing p21 (Fig. 1B).
Effects of Sp1-interacting proteins on Sp1-promoter
We used the minimal promoter of the Sp1 gene (pGL3FOR2), which is mainly regulated
through two Sp1 sites,12 to test the effect of the Sp1-interacting proteins. SKP2, Rad51, CDK4,
BRCA2 and p21 showed significant transcriptional activation of the Sp1 promoter (Fig. 2A).
In addition, Rb, Stat3 and CyclinD1 activated the Sp1 promoter, whereas p53 and NFκB
decreased Sp1 promoter activity by more than 50%. E2F/DP1 was an activator of Sp1
transcription as previously described.12
To better characterize the effect of Sp1-interacting proteins on Sp1-dependent regulation, we
used two Sp1 promoter constructs containing different point mutations: pSdNmut, bearing
mutations at the NF-Y site and one of the Sp1 boxes, and pSNSmut, with the NF-Y and both
Sp1 boxes mutated (scheme in Fig. 2B). All the Sp1-interacting proteins had the same effect
on pSdNmut as on the wild type promoter (Fig. 2B). In contrast, a decrease in promoter activity
was observed when the two Sp1 boxes were mutated, demonstrating the relevance of the Sp1
binding site for the effect of the interacting proteins.
Overexpression of IκB and a dominant negative mutant of p53 caused activation of the Sp1
promoter whereas dominant negatives of Rb and Stat3 decreased the activity of the construct
(data not shown). The combination of BRCA2 and Rad51 produced a slight further increase
in SP1 promoter-luciferase activity compared to the effect caused by overexpression of each
protein alone (Fig. 3A).
Different combinations of cell cycle regulators p53, p21, CDK4, CyclinD1, Rb and E2F1 were
also tested for their effect on the Sp1 promoter. As shown in Figure 3B, p53 was able to
counteract p21-induced activation of Sp1 promoter. Moreover, the combination of p21 and
CDK4 activated Sp1 promoter but to a lower extend than p21 alone. The combination of p21
and Rb caused an increase in Sp1 promoter, to a higher level than p21 or Rb alone. Additionally,
the combination of Rb and CDK4 also increased Sp1 promoter activity and this effect was
additive compared to the activation caused by either Rb or CDK4 alone. Finally, the
combination of Rb with E2F activated Sp1 promoter to an intermediated level, higher than E2F
alone but lower than Rb alone.
Regulation of the endogenous Sp1 gene
To study the effect of the interacting proteins on the endogenous levels of Sp1, we performed
RT- Real Time PCR to quantify Sp1 mRNA levels in HeLa cells after the overexpression of
these proteins. As shown in Figure 4, overexpression of p53 and NFκB decreased Sp1 mRNA
levels more than 50%, whereas E2F1, p21, Cyclin D1, Stat3, SKP2, Rad51, CDK4, BRCA2
and Rb, increased the Sp1 mRNA levels significantly, in accordance with the results on Sp1
promoter activity. All the changes were in keeping with the changes in the transcriptional
activity of the Sp1 promoter measured in the luciferase assays (Figs. 2 and 3).
Sp1-interacting proteins are bound to the Sp1 promoter in vivo
To examine whether the effects of the exogenous Sp1-interacting proteins on Sp1 transcription
reflected the interaction of the corresponding endogenous proteins with the native Sp1
promoter, we performed ChIP analysis of chromatin from HeLa cells using specific antibodies
against different proteins. As shown in Figure 5, amplification of the Sp1 promoter was
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observed from chromatin immunoprecipitated using antibodies against Sp1, Stat3, SKP2,
NFκB, p21, p53, BRCA2, CDK4 and E2F, demonstrating that both Sp1 and the endogenous
Sp1-interactive proteins are bound at the Sp1 promoter containing Sp1-binding sites present
in the Sp1 promoter. In the Real Time results, a control region was used for normalization.
Effect of Sp1-interacting proteins on an artificial Sp1-dependent promoter
To test if the effects observed with the Sp1 gene promoter were a general mechanism that could
affect other Sp1-regulated promoters, we used a luciferase construct with a promoter that
contained five tandem Sp1 binding sites (pG5-5x(GC)-Luc).14 As shown in Figure 6A, p53
and NFκB were able to significantly decrease promoter activity whereas Rb, SKP2, E2F1/DP1,
Stat3, BRCA2 and p21 increased promoter activity by 2-fold. CDK4, Rad51, CyclinD1 had
no effect on the artificial promoter controlled by Sp1.
The effects of E2F1 and Rb overexpression were also analyzed using a construct in which the
Sp1 sites were deleted. As shown in Figure 6B, the activity of this construct was almost
abolished with the elimination of the Sp1 sites, and the addition of either E2F or Rb did not
increase significantly the promoter activity. Altogether these results indicated that the effects
of E2F and Rb are due to a direct interaction with Sp1.
Effect of p21 on Sp1-dependent transcription
Given that p21 caused the higher effects on the Sp1 promoter and that p21 expression has been
shown to result in multiple changes in gene expression in human HT1080 fibrosarcoma and
other cell lines,15,16 we further characterized the effect of p21 on Sp1. Transient transfection
used in the other experiments leads to very high and often supraphysiological expression levels
of the transfected protein, and therefore we used HT1080 p21-9 cells with stably integrated
p21 which is inducible by IPTG (isopropyl-β-thio-galactoside) to the levels that are similar to
those observed in response to DNA damage or at the onset of senescence.15 First, we confirmed
by coimmunoprecipitation that the interaction between Sp1 and p21 takes place in HT1080
p21-9 cells (Fig. 7A). Then, we transfected HT1080 p21-9 with the Sp1 promoter construct
pSdNmut. p21 induction by IPTG increased Sp1 promoter activity in a dose-dependent manner
(Fig. 7B), thus confirming our previous results with transiently transfected p21. Moreover,
endogenous Sp1 mRNA levels increased up to 2-fold after 72 h of IPTG addition (Fig. 7C).
Finally, the artificial promoter controlled exclusively by Sp1 was activated by 2-fold after IPTG
addition (Fig. 7D).
To confirm Sp1 induction by p21 as observed at the RNA level through protein analysis, Sp1
protein levels were analyzed after IPTG addition. Surprisingly, p21 induction caused a decrease
rather than an increase in Sp1 protein levels (Fig. 8A). To determine whether this effect on Sp1
protein levels was due to an increase in Sp1 degradation we tested the effect of the calpain
inhibitor E64d on p21-induced Sp1 depletion. Incubation of p21-9 induced cells with E64d for
24 hours not only prevented the decrease in the Sp1 protein but also increased its levels up to
190% of the control (Fig. 8C). This result is consistent with previously observed induction of
Sp1 mRNA by p21 and suggests that Sp1 depletion was due to protein degradation. Incubation
of p21-9 cells with E64d for longer periods of time also caused the inhibition of p21 degradation
and its accumulation (data not shown). Incubation of HT1080 p21-9 cells with IPTG in the
presence of E64d for 24 hours after transfection with either Sp1 promoter or Sp1-dependent
promoter constructs caused an increase in the activity of both constructs, as compared to control
cells or to cells incubated with IPTG alone (Fig. 8D).
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Protein-protein interactions among sequence-specific DNA-binding transcription factors
suggest novel modes of regulation. One DNA-bound transcription factor can recruit a second
factor to the promoter where binding sites for the latter are absent. The aim of this work was
to identify new Sp1-interacting proteins and to study the regulation of the Sp1 promoter by
such proteins. Interactions between Sp1 and cell cycle regulators have been well documented
and some of the proteins that interact with Sp1 are able to bind among themselves, suggesting
that Sp1 could be part of different protein complexes. The results of the present study expand
the network of SP1 interactions and suggest new links of SP1 to cell cycle controlling proteins
(Fig. 9).
We previously described the interaction between Sp1 and the retinoblastoma gene product Rb.
5 Rb is a target of the cyclin/CDK complexes, mainly CDK4/cyclinD, and its function depends,
at least in part, on the interactions with the E2F family of DNA-binding transcription factors.
17 E2F1 and CDK2 also interact with Sp1 forming stable complexes.5,10,18 In the present
work we demonstrate that Sp1 is able to bind to CDK4 and a CDK inhibitor p21.
Overexpression of all these cell cycle regulators (CDK4, Rb, cyclinD1, E2F and p21) increased
Sp1 promoter activity and Sp1 mRNA levels. Although it could had been expected that p21
decreased CDK4 activity, the combined overexpression of p21 and CDK4 results in a higher
transcription than in CDK4 alone, although lower than with p21. This is in agreement with the
fact that p21 plays a permissive role in cell cycle progression as a consequence of its ability to
cooperate with CDK4, and to function as an assembly factor for CyclinD-CDK4 complex, as
reported in.19-21 One might expect that the combination of Rb and CDK4 would lead to a
change in the phosphorylation state of Rb. However, since the interaction between Sp1 and Rb
is independent of Rb phosphorylation state,5 the combination of Rb and CDK4 produces an
additive effect in Sp1 transcription. In keeping with this observation and taking into account
that p21 activates Rb dephosphorylation,22 the combination of p21 and Rb caused the activation
of the Sp1 promoter. In the case of combining E2F and Rb, the resulting effect on Sp1
transcription is mainly due to Rb, present in its hypophosphorylated form, which is able to
repress E2F, either by sequestering this factor or by turning E2F into an active repressor.17
E2F and Rb were able to activate the artificial promoter containing only Sp1 sites
demonstrating that their effect on the Sp1 gene promoter was mediated directly by Sp1-
interaction. On the contrary, overexpression of Cyclin D1 and CDK4 had no effect on this
promoter suggesting that they might need the presence of additional factors rather than Sp1
alone to activate Sp1 transcription.
Another complex interacting with Sp1 is SCFskp2 that plays an important role in the ubiquitin-
mediated degradation of some cell cycle proteins such as p27,23 and some transcription factors
such as E2F1.24 The SCFskp2 complex is composed of four subunits: cullin, SKP1, RBX1 and
the F-box protein SKP2.25 The first three proteins form a common scaffold onto which
different F-box proteins can be assembled, conferring specificity to the complex. Cdc34 is also
included in this complex and enables transfer of the ubiquitin molecule to specific targets.26
Cdc34, p19Skp1, RbX1&2 and p45SKP2 are present in the antibody array and gave positive
signals for Sp1 interaction. Given that SKP2 is the F-box of the complex and recognizes the
substrate, we validated its interaction with Sp1 by co-immunoprecipitation. Different studies
have suggested a close link between the activator function of many transcription factors and
their ubiquitylation/degradation.27 Our data demonstrate that SKP2, instead of degrading Sp1,
activates the Sp1 promoter and increases Sp1 mRNA levels and protein levels up to 2-fold
(data not shown). This effect has also been observed for the interaction between c-myc and
SKP2.28 It is conceivable that Sp1 could be recruiting SCFSKP2 to the promoter to degrade
negative regulators of transcription at the promoter level. This hypothesis is supported by the
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results of the ChIP assays that were positive for SKP2 at the Sp1 promoter level and with the
result that SKP2 also activates the artificial promoter containing only Sp1 boxes.
BRCAs are tumor suppressor genes involved in multiple pivotal cellular processes. These
proteins contribute to DNA repair, transcriptional regulation in response to DNA damage and
maintenance of chromosomal stability, thereby protecting the genome from damage. Many of
these functions are mediated by a large number of cellular proteins that interact with BRCAs.
29 The interaction between BRCA1 and Sp1 has been described for the regulation of IGF-IR
gene expression.30 Here we show that Sp1 is able to bind to BRCA2 in addition to BRCA1
and that this interaction increases Sp1 promoter activity and Sp1 mRNA endogenous levels.
Moreover, BRCA2 is able to activate a promoter driven only by Sp1 indicating that BRCA2
interacts with Sp1 and that additional factors present in the Sp1 promoter are not necessary for
the resulting activation. Rad51 and RBBP are additional components of the repair machinery
present in the antibody array that originated positive spots for Sp1 interaction. The interaction
of Sp1 with Rad51 was also confirmed by co-immunoprecipitation. Rad51 was able to activate
Sp1 transcription at the promoter and mRNA levels. However, Rad51 did not affect Sp1-
dependent activation of the promoter containing only Sp1 binding sites. Combination of
BRCA2 and Rad51 increased Sp1 promoter activity to a moderate degree, suggesting that they
are forming a part of a complex in which more proteins are needed for the maximum increase
in Sp1 transcription. The interaction between BRCA2 and Rad51 has been reported31 and there
is genetic evidence that it is fundamental for the maintenance of cell division and chromosome
structure.29
Sp1 interactions with other proteins also involve several transcription factors: Stat1, Stat3, p53
and NFκB. Tumor suppressor p53 is involved in transcriptional activation of important genes,
such as p21, in the regulation of cell cycle and apoptosis32 and it is involved both in DNA
damage and in cell cycle control. In our experiments, p53 overexpression decreased the activity
of the Sp1 promoter. Transcriptional repression of other genes by p53 revealed that Sp1 was
prevented from binding to the promoter region by a p53-Sp1 protein complex.33-35 Our results
are in keeping with these observations; p53 counteracted the positive effect of p21 on Sp1
transcription, probably because Sp1 is prevented by p53 from binding to its binding site.
NFκB is a nuclear effector in a signaling pathway responsive to a large number of extracellular
stimuli in many cells.36 NFκB is capable of participating in the transcriptional regulation of
target genes, independently of its DNA binding site, through cooperation with other
transcription factors. NFκB and Sp1 bind cooperatively and activate transcription of the human
immunodeficiency virus synergistically.37 Additionally, NFκB has been described as a
transcriptional inhibitor for the gluconeogenic enzyme PEPCK by sequestration of a co-
activator protein such as CBP.38 Accordingly, in our model NFκB behaved as a repressor of
Sp1-dependent activation of both the Sp1 promoter and the artificial promoter.
Stats are a family of transcription factors involved in ligand-dependent growth stimulation or
differentiation as well as in antiproliferative effects.39,40 Both Stat1 and Stat3 have been
reported to interact with Sp1.41,42 Stat3 activates transcription of VEGF through its interaction
with a Sp1/DNA complex and not by its direct binding to a palindromic enhancer element.42
In agreement with these observations, in our conditions, Stat3 is an activator of both Sp1
promoter and the artificial promoter, and it binds to the Sp1 promoter.
p21 was studied in further detail as it was able to strongly activate the Sp1 promoter and there
are several reports showing that p21 affects transcription of many different genes.15,43,44 We
tested the effects of p21 on Sp1 promoter and Sp1 mRNA levels in HT1080 p21-9 cells, which
carry a stably integrated p21 transgene inducible by IPTG addition to physiologically
meaningful levels. We confirmed that p21 was able to activate transcription form the Sp1
promoter and to increase Sp1 mRNA expression in this system, as previously observed in HeLa
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cells transiently transfected with p21. The activation of Sp1 at the promoter and mRNA levels
after p21 induction is in accordance with previous observations using CDK inhibitors.45 This
effect could be caused by dephosphorylation of Sp1 at concrete sites that could increase its
transcriptional activity directly or increase the degradation of its inhibitory domain.8 An
increase in Sp1 transcriptional activity would increase Sp1 transcription as Sp1 is positively
autoregulated.
To further characterize the effects of p21 on Sp1, we analyzed the effect of p21 on Sp1 protein
levels by Western blot. Surprisingly, p21 induction did not increase but rather reduced Sp1
protein levels by 80%. The decrease in Sp1 protein levels observed after 24 hours of p21
induction was reverted by the protease inhibitor E64d, indicating that p21 induced Sp1 protein
degradation. Both Sp1 full length and the cleaved form were able to activate either the Sp1
promoter or an Sp1-dependent promoter construct as determined in luciferase assays in
HT1080 p21-9 cells incubated with IPTG in the absence or in the presence of E64d.
The effect of p21 on Sp1 protein levels was in accordance with Sp1 degradation in aged animal
tissues as well as in cells undergoing replicative senescence,3,46,47 where p21 induction plays
a pivotal role.22 p21 was previously found to promote the degradation of key cell cycle
regulatory proteins, including p53,48 and Rb;49 the latter protein can be degraded through the
same pathway as Sp1.50 Aside from recruiting Sp1 into this proteolytic pathway, p21, as
mentioned above, could potentially cause dephosphorylation of Sp1 increasing the degradation
of its inhibitory domain, converting Sp1 into a more unstable protein.8 The dual effect of p21
on Sp is similar to its effect on Rb, where p21 activates Rb by dephosphorylation and
concomitantly inactivates it by triggering its degradation.49
In summary, Sp1 function and transcription are regulated by different cell cycle related proteins
identified by their interaction with Sp1 protein. Multiple effects of cell cycle regulators on Sp1,
observed in the present study, suggest that Sp1 may be a key mediator of cell cycle associated
changes in gene expression.
Materials and Methods
Plasmid constructs
pGL3FOR2, containing the minimal promoter of Sp1, and pSdNmut and pSNSmut, containing
point mutations for the Sp1 and NF-Y boxes on the Sp1 promoter, have been previously
described in detail11 and in a scheme presented in Figure 2.
pG5-5x(GC)-Luc contains the luciferase gene controlled by five tandem Sp binding sites and
was a generous gift from Dr. Man-Wook Hur. pG5-Luc was engineered by deletion of the five
tandem Sp binding sites.
The expression vectors for the different proteins used in this study were obtained from the
following investigators: Sp1 (Dr. R. Tjian), E2F1 and DP1 (Dr. T. Kouzarides), pCMV-Cip1
(p21) (Dr. S. Elledge), Stat3 (Dr. J.C. Lacal), PC53-SN3 (Dr. B. Vogelstein), p45SKP2 (Dr.
C. Serra-Pagès), Rad51 (Dr. M. Defais), BRCA2 (Dr. J. Bueren), NFκB (Dr. C. Caelles),
CyclinD1 (Dr. N. Agell), CDK4 (Dr. M. Barbacid) and Rb (Dr. W.G. Kaelin).
Cell culture
HeLa human cervical carcinoma cells were grown in Ham's F-12 medium supplemented with
5% foetal bovine serum (Invitrogen). p21-9 cells were grown in DMEM/GlutaMAX
supplemented with 10% foetal calf serum (Invitrogen). Cultures were maintained at 37°C in a
humidified 5% CO2-containing atmosphere. The derivation, maintenance and p21 induction
by IPTG in HT1080 p21-9 cells has been previously described.13
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Screening of the antibodyarray
HeLa total extracts were prepared in extraction solution at 4°C (120 mm NaCl, 25 mm KCl, 2
mm EGTA, 1 mm EDTA, 0.1 mm DTT, 15 mm Tris-HCl, pH 7.5, 0.5% Triton X-100, 10 mg/
mL leupeptin, 0.5 mm phenylmethylsulfonyl fluoride). The debris was removed by
centrifugation (10,000 g, 15 min).
HeLa total extracts were diluted at a concentration of 2 mg/ml in extraction solution containing
1% dry milk. Subsequently, the total extract was incubated with the AntibodyArray™ (Cell
Cycle array, Hypromatrix) containing 60 antibodies, as indicated by the manufacturer (see list
at http://www.hypromatrix.com). Briefly, the AntibodyArray™ was blocked with 5% dry milk
in TBST (150 mm NaCl, 25 mm Tris-HCl, 0.05% Tween-20, pH 7.5) for 1h at room
temperature. Then, the membrane was incubated for 2 h at room temperature with the total
extract, and washed in TBST (3 × 15 min). The membrane was incubated with biotinylated
anti-Sp1 antibody (PEP 2, Santa Cruz) and then with streptavidin peroxidase. Binding of the
Sp1 antibody was detected by enhanced chemiluminiscence, as recommended by the
manufacturer (GE Healthcare).
Co-immunoprecipitations
HeLa total extracts were prepared by incubation in extraction solution for 30 minutes on ice
(50 mM Tris-HCl pH 8, 50 mM KCl, 5% Glicerol, 0.1 mM EDTA, 0.5% NP-40, 1 mM PMSF,
10 mg/ml Leupeptin). Cell debris was removed by centrifugation (10,000 g, 10 min). In the
case of p21 immunoprecipitation, 5 × 105 HeLa cells were transfected with 5 μg of p21
expression vector using FUGENE™ 6 (Roche Applied Science) 48 h before preparation of the
extracts. Total extracts from HeLa cells were immunoprecipiated using specific antibodies
(Santa Cruz) for Sp1 (PEP 2), BRCA2 (H-300), SKP2 (H-435), Rad51 (H-92), CDK4 (H-22),
p21 (C-19) or unspecific IgGs (Sigma) with the aid of Protein G-Sepharose (GE Healthcare).
Then, the pellets were washed three times in extraction solution, resolubilized in loading buffer,
boiled for 10 minutes and subjected to Western blot analysis using anti-Sp1 antibody (PEP 2,
Santa Cruz) as described in.5
For the immunoprecipitation using HT1080 p21-9 cells, cells were treated with 50 μM IPTG
and 24 hours later, total extracts were prepared as described above. These cell extracts were
immunoprecipitated using specific antibodies for Sp1 (PEP 2) or IgGs as described above and
subjected to Western blot analysis using anti-p21 antibody (C-19, Santa Cruz).
Cotransfections and luciferase assays
HeLa cells were seeded into 6-well plates the day before transfection at a density of 2 × 105
cells/well in Ham's F12 medium containing 5% foetal bovine serum. The medium was renewed
before transfection, which was performed using FUGENE™ 6 (Roche Applied Science). For
each well, 3 μl of FUGENE™ 6 in 100 μl of serum-free F-12 medium was incubated at room
temperature for 5 min. The mixture was added to the vectors used. In cotransfections, 250 ng
of the constructs pGL3FOR2, pSdNmut or pSNSmut, described in11 or pG5-5x(GC)-Luc or
pG5-Luc, were mixed with the indicated amounts of Sp1, E2F, DP1, p21, CyclinD1, Stat3,
p53, SKP2, NFκB, p21, CDK4, BRCA2 and Rb expression vectors before the addition of
FUGENE™ 6 in serum-free F-12 medium.
Luciferase activity was assayed 30 h after transfection. Cell extracts were prepared by lysing
the cells with 200 μl of freshly diluted 1× Reporter Lysis Buffer (Promega). The lysate was
centrifuged at 12,000 g for 2 min to pellet the cell debris. The supernatants were transferred to
a fresh tube and a 30 μl-aliquot of the extract was added to 30 μl of the luciferase assay substrate
(Promega). The luminiscence of the samples was read after 10 min on a Glomax™ 20/20
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Luminometer, in which the light production (relative luminiscence units) was measured for 10
seconds. Each transfection was performed in triplicate.
Transfection efficiency was corrected by by normalizing the firefly luciferase activity
expressed from tested promoter by the control renilla luciferase resulting from cotransfection
with the pCMV renilla luciferase vector. 30 μl of the Stop & Glo solution were added to the
luciferase mix after reading luciferase activity and were incubated for 10 min before reading
the luminescence. Alternatively, when overexpression of the plasmid increased the renilla
activity, luciferase results were corrected by protein concentration using the Bio-Rad protein
assay reagent according to the manufacturer's protocol.
For luciferase assays with HT1080 p21-9 cells, cells were seeded into 6-well plates the day
before transfection at a density of 2 × 105 cells/well in DMEM/Glutamax medium containing
10% foetal calf serum. The medium was renewed before transfection, which was performed
using FUGENE™ 6 (Roche Applied Science). For each well, 3 μl of FUGENE™ 6 in 100 μl
of serum-free F12 medium was incubated at room temperature for 5 min. The mixture was
added to the vectors used. 24 hours after transfection, cells were split and IPTG was added to
the medium at the indicated concentrations in one of the two wells corresponding to one
transfection. Cells were collected at the indicated times and luciferase activity was measured
using the Dual Luciferase Reporter Kit (Promega) according to the manufacturer's instructions.
Renilla activity determined for cells in the absence of IPTG was used to normalize the results.
For the E64d treatments, 3 μg/ml of E64d were added to the medium together with IPTG and
luciferase was measured after 24 hours.
ChIP analysis
Formaldehyde cross-linking and ChIP were performed as described in.51,52 Briefly, HeLa cells
(semiconfluent 100 mm dish) were washed with phosphate-buffered saline and incubated for
10 minutes with 1% formaldehyde. The reaction was quenched with 0.1 M glycine and cells
were sonicated to obtain chromatin fragments of an average length of 500 to 800 bp.
Immunoprecipitation was performed with protein G-Sepharose (GE Healthcare) and 5 μg of
antibodies (Santa Cruz) specific for Sp1 (PEP 2), BRCA2 (H-300), SKP2 (H-435), Rad51
(H-92), CDK4 (H-22), Stat3 (H-190), E2F-1 (C-20), p53 (FL-393) and NFκB p65 (A) or 10
μg of antibodies Rb (C-15) and p21 (C-19). Non-specific IgG (Sigma) was used as a negative
control. The chromatin solution was pre-cleared by incubation with protein G-sepharose for 2
h at 4°C, divided into aliquots, and incubated overnight with different antibodies. Before use,
protein G-Sepharose was blocked with herring sperm DNA (1 μg/μl) (120–3000 nucleotides
length) and BSA (1 μg/μl) for 2 h and then overnight, all at 4°C.
Sp1 promoter was amplified by PCR using the following specific primers:
Fwd 5′- GCAAGCGAGTCTTGCCATTGG -3′
Rev 5′- CGCTCATGGTGGCAGCTGAGG -3′
PCR was performed in a final volume of 30 μl for at least 28 cycles. Then, 10 μl samples of
the PCR products were electrophoresed in a 2% agarose gel and the amplified fragments were
visualized after EtBr staining.
For quantification, amplification was performed by Real Time-PCR in an ABI Prism 7000
Sequence Detection System (Applied Biosystems) with 2 μl of immunoprecipitated DNA and
the primers indicated above using the Fast SYBR Green Master Mix (Applied Biosystems).
The reaction was performed following the manufacturers recommendations. The percent of
input was calculated by the standard ΔΔCt method. As a negative control, the following primers
were also used:
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These negative control primers flank a region of genomic DNA between the GAPDH gene and
the chromosome condensation-related SMC-associated protein (CNAP1) gene.
Sp1 mRNA endogenous levels
1 μg of expression vectors for E2F, DP1, p21, CyclinD1, Stat3, p53, SKP2, NFκB, p21, CDK4,
BRCA2 and Rb was transfected using Fugene 6.
Total RNA was extracted from HeLa cells using the Ultraspec™ RNA reagent (Biotecx) in
accordance with the manufacturer's instructions.
cDNA was synthesized in a total volume of 20 μl from RNA samples by mixing 1 μg of total
RNA, 125 ng of random hexamers (Roche Molecular Biochemicals), in the presence of 75 mM
KCl, 3 mM MgCl2,10 mM dithiothreitol, 20 units of RNAsin (Promega), 0.5 mM dNTPs
(AppliChem), 200 units of M-MLV reverse transcriptase (Invitrogen) and 50 mM Tris-HCl
buffer, pH 8.3. The reaction mixture was incubated at 37°C for 60 min. The cDNA product
was used for subsequent amplification by Real Time-PCR.
Sp1 mRNA levels were determined in an ABI Prism 7000 Sequence Detection System (Applied
Biosystems) using 3 μl of the cDNA mixture and the Assays-on-demand Hs00412720_m1 for
Sp1 and Hs99999901_s1 for 18S RNA (both from Applied Biosystems). 18S RNA was used
as an endogenous control. The reaction was performed following the manufacturers
recommendations. Fold-changes in gene expression were calculated using the standard ΔΔCt
method.
Sp1 protein levels measurement
HT1080 p21-9 total extracts were prepared in extraction solution for 1 hour at 4°C (50 mM
Hepes, 0.5 M NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% Glicerol (V/V), 1% Triton X-100,
Protease inhibitor cocktail). Cell debris was removed by centrifugation (10,000 g, 10 min).
Cells extracts were resolved on SDS-7% or 12% polyacrylamide gels,53 and transferred to a
PVDF membrane (Immobilon P, Millipore) using a semidry electroblotter. The membranes
were probed with antibodies against Sp1, p21 (both from Santa Cruz) or Actin (Sigma). Signals
were detected by secondary horseradish peroxidase-conjugated antibody (1:2500 dilution) and
enhanced chemiluminiscence, as recommended by the manufacturer (GE Healthcare).
Quantification of the bands was performed using the ImageQuant software (Molecular
Dynamics).
Statistical analysis
Data are presented as mean ± SEM. Statistical analysis was performed using Student's t test
using SPSS 13 software for Macintosh. p values of less than 0.05 were considered statistically
significant.
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Coimmunoprecipitation of Sp1 with BRCA2, SKP2, Rad51, CDK4 and p21. (A)
Immunoprecipitates were obtained from 1 mg of HeLa total cell extract by incubation with 5
μg of the indicated specific antibodies. After washing, the bound proteins were resolubilized
and Sp1 protein was detected by Western analysis. The first lane (TE) shows the signal
corresponding to Sp1 from 200 μg of HeLa total extract. (B) Coimmunoprecipitation using
p21-antibody. 5 μg of p21 expression vector were transfected into HeLa cells using Fugene 6.
Total extracts were obtained and 1 mg of each extract was used for coimmunoprecipitation
with p21 antibody. Other conditions were as in Figure 1A.
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Regulation of Sp1 promoter by overexression of Sp1-interacting proteins. (A) HeLa cells were
cotransfected with 250 ng of pGL3FOR2 (scheme at upright A) and 500 ng of the indicated
expression vectors. After 30 h, cell lysates were assayed for luciferase activity. Firefly
luciferase activity was normalized to the renilla luciferase activity for each sample. Results are
expressed relative to the activity obtained upon transfection with pGL3FOR2 alone. (B) HeLa
cells were cotransfected with 250 ng of pSdNmut or pSNSmut (scheme at upright B) together
with 500 ng of the indicated expression vectors. Results are expressed relative to the activity
obtained upon transfection with pSdNmut alone. Other conditions were as in Figure 3A. Results
represent the mean ± SE of 3 different experiments. *p < 0.05, **p < 0.01 and ***p < 0.001
Results are expressed relative to the pGL3FOR2 or pSdNmut constructs alone.
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Effect of overexpression of different combinations of Sp1-interacting proteins on Sp1 promoter
activity. (A) Combination of the DNA-repair proteins Rad51 and BRCA2. Cells were co-
transfected with 250 ng of pSdNmut and the indicated amounts of BRCA2 and/or Rad51. After
30 h, cell lysates were assayed for luciferase activity. Other conditions were as in Figure 2B.
(B) Different combinations of cell cycle regulators p53, p21, CDK4, Rb, E2F and cyclinD1.
HeLa cells were co-transfected with 250 ng pSdNmut construct and the indicated amounts of
the corresponding expression vectors. Other conditions were as in Figure 2B.
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Effect of Sp1-interacting proteins on Sp1 endogenous levels. HeLa cells were transfected with
1 μg of the indicated expression vectors using 3 μl of FUGENE™ 6. After 72 h RNA was
extracted and RT-Real Time PCR was performed as described. Results are expressed relative
to the Sp1 mRNA levels obtained upon transfection with the empty vector pCMV. Results
represent the mean ± SE of 3 different experiments and are expressed relative to the control
using a CMV vector without insert. *p < 0.05, **p < 0.01 and ***p < 0.001.
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ChIP analysis of the Sp1 promoter. ChIP assays for the Sp1 promoter region were performed
using HeLa cells. DNA bound to the immunoprecipitated Sp1, SKP2, Stat3, NFκB, p53, E2F1,
Rad51, CDK4, BRCA2, Rb and p21 using specific antibodies, was amplified by PCR. Rabbit
IgG was used as negative control (marked as C-). (A) Representative images of the PCR
products corresponding to the amplification for each antibody using Sp1- specific primers are
shown. (B) Quantification of ChIP analysis was performed by Real Time PCR and results are
expressed as percent of the input, taking into account that ΔCt (Sp1) = Ct Sp1 promoter - Ct
genomic DNA, ΔΔCt = ΔCt (Sp1) - ΔCt (IgG) and then referred to the input, considering the
dilution factor.
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Effect of Sp1-interacting proteins on an artificial promoter containing only Sp1-binding sites.
(A) HeLa cells were cotransfected with 250 ng of pG5-5x(GC)-Luc and 500 ng of the indicated
expression vectors. (B) HeLa cells were cotransfected with 250 ng of pG5-5x(GC)-Luc or pG5-
Luc and 500 ng of the indicated expression vectors. In all cases, after 30 h, cell lysates were
assayed for luciferase activity. Firefly luciferase activity was normalized to the renilla
luciferase activity for each sample. Results are expressed relative to the activity obtained upon
transfection with pG5-5x(GC)-Luc and pCMV. Results represent the mean ± SE of 3 different
experiments and are expressed compared to the pG5-5x(GC)-Luc construct cotransfected with
500 ng of an empty CMV vector. *p < 0.05, **p < 0.01 and ***p < 0.001 Results are expressed
relative to the pGL3FOR2 or pSdNmut constructs alone.
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Effect of inducible p21 on Sp1-dependent function and expression. (A)
Coimmunoprecipitation of p21 with Sp1. Immunoprecipitates were obtained from 1 mg of total
cell extracts from HT1080 p21-9 treated with 50 μM IPTG, by incubation with 5 μg of the
indicated specific antibodies. After washing, the bound proteins were resolubilized and p21
protein was detected by Western analysis. The first lane (TE) shows the signal corresponding
to p21 from 50 μg of induced HT1080 p21-9 cells total extract. (B) Effect of p21 induction on
Sp1 promoter. HT1080 p21-9 cells were cotransfected with 500 ng of pSdN construct before
induction with increasing amounts of IPTG. At indicated times, cells were assayed for
luciferase activity. Firefly luciferase activity was normalized to renilla luciferase activity as
described in Materials and Methods. Results are expressed relative to the activity obtained
upon transfection with pSdN without IPTG addition. (C) Effect of p21 induction on Sp1 mRNA
levels. HT1080 p21-9 cells were treated with the indicated amounts of IPTG. After 72 h RNA
was extracted and RT-Real Time PCR was performed as described. Results are expressed
relative to the Sp1 mRNA levels obtained without adding IPTG. (D) Effect of p21 induction
on a promoter containing only Sp1-binding sites. HT1080 p21-9 cells were transfected with
the pG5-5x(GC)-Luc vector and IPTG was added to the medium at the concentrations
indicated. Results are expressed relative to the activity obtained upon transfection with pG5-5x
(GC)-Luc without IPTG addition. Results represent the mean ± SE of 3 different experiments.
*p < 0.05, **p < 0.01 and ***p < 0.001 compared to the pSp3-FOR4 construct alone.
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Effect of p21 induction on Sp1 protein levels. (A) Sp1, p21 and Actin protein levels were
determined by Western Blot in HT1080 p21-9 cells after the addition of 50 μM IPTG at
different times. (B) Quantification of the results presented in (A). Quantification was performed
using ImageQuant software (Molecular Dynamics). The representation is in a semilogarithmic
scale. (C) Immunoblotting of Sp1, p21 and Actin in HT1080 p21-9 cells treated for 24 hours
with 50 μM IPTG and 3 μg/ml of the inhibitor E64d (Sigma). (D) Effect of E64d on Sp1 and
Sp1-regulated promoters. HT1080 p21-9 cells were cotransfected with 250 ng of pGL3FOR2
or pG5-5x(GC)-Luc constructs before the addition of 50 μM of IPTG and 3 μg/ml of E64d.
Results represent the mean ± SE of 3 different experiments. *p < 0.05.
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Network diagram of Sp1-interacting proteins. Different Sp1-interacting proteins are presented.
This interaction network was created with the aid of software Pathway Architect 2.01
(Stratagene), and represents both the previously known and the newly discovered binding
associations among all of these proteins.
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